Showing 1 posts of 1 posts found.
Over recent years the pharmaceutical industry has been unable to escape the mantra of return on investment (ROI). Investment in …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement